Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2007
11/06/2007CA2267322C Pde iv inhibiting 2-cyanoiminoimidazole derivatives
11/01/2007WO2007124322A1 Inhibitors of c-fms kinase
11/01/2007WO2007124319A1 Inhibitors of c-fms kinase
11/01/2007WO2007124318A1 Inhibitors of c-fms kinase
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007123111A1 Compound, organic electroluminescence element containing the compound, illuminating device and display device
11/01/2007WO2007122847A1 Reagent for organic synthesis and method of organic synthesis reaction with the reagent
11/01/2007WO2007122401A1 Imidazole derivatives for use as edg-1 antagonists
11/01/2007WO2007122341A2 Specific monocationic monochromophoric hydrazone compounds containing a 2-(benz)imidazolium unit, their synthesis, dyeing compositions comprising them, method of dyeing keratin fibres
11/01/2007WO2007106022A3 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof.
11/01/2007WO2007087135A3 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007047146A3 Inhibitors of viral replication
11/01/2007US20070255064 Imidazolium-Methyl Sulfites for Use as Starting Compounds for Producing Ionic Liquids
11/01/2007US20070255057 Mono-nitration of aromatic compounds via nitrate salts
11/01/2007US20070254935 Pyrazole and imidazole compounds and uses thereof
11/01/2007US20070254890 4(Phenyl-Piperazinyl-Methyl) Benzamide Derivatives and Their Use for the Treatment of Pain or Gastrointestinal Disorders
11/01/2007US20070254318 Inhibition of cell proliferation
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2649919A1 Phenyl-and pyridinyl amide inhibitors of c-fms kinase
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649512A1 C-fms kinase inhibitors
10/2007
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1848696A1 Imidazole and benzimidazole derivates useful as histamine h3 antagonists
10/31/2007EP1848428A2 Thiazole amides, imidazole amides and related analogues
10/31/2007EP1509525B9 Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/30/2007US7288660 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
10/30/2007US7288571 Thyroid receptor ligands and method II
10/30/2007US7288559 Carboxamide spirohydantoin CGRP receptor antagonists
10/30/2007US7288541 Propylcarbamate derivatives as inhibitors of serine and cysteine proteases
10/30/2007US7288536 For therapy of skin diseases such as eczema, psoriasis, allergic dermatitis neurodermatitis, pruritis and hypersensitivity reactions; inflammatory conditions of the nose, throat or lungs such as asthma (including allergen-induced asthmatic reactions), rhinitis (including hayfever), nasal polyps
10/30/2007CA2172571C Hydroxy-functional prepolymers containing hydantoin group precursors and their use in coating compositions
10/25/2007WO2007121390A1 Process for making cytokine inhibiting compounds containing 4- and 5- imidazolyl rings and the intermediates thereof
10/25/2007WO2007120647A2 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007WO2007119246A2 An improved process for the manufacture of losartan potassium
10/25/2007WO2007073518A3 Compounds and methods for thiol-containing compound efflux and cancer treatment
10/25/2007US20070249843 Process for the Synthesis of Imidazoles
10/25/2007US20070249833 such as 2-bromo-1-[6-(4-methyl-imidazole-1-yl)-pyridin-3-yl]-ethanone, which have activity in modulating levels of amyloid-beta, useful in the treatment of neurodegenerative diseases, such as Alzheimer's disease
10/25/2007US20070249698 Diarylimidazoles, substituted with another aromatic ring and one or more carboxylic acids, esters or amides, e.g., 3-[5-Benzo[1,3]dioxol-5-yl-4-(2,5-dichloro-phenyl)-1H-imidazol-2-yl]-2-(3-chloro-phenyl)-acrylic acid; treatment of conditions such as pain, drug dependence, and psychological disorders
10/25/2007US20070249697 3-[3-(3-chloro-4-cyanophenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl]propane-1-sulfonic acid amide; anti-androgen activity; treatment of prostate cancer, benign prostatic hypertrophy, male pattern baldness, sexual precociousness, common acne, seborrhea
10/25/2007US20070249691 Mercaptoimidazoles as Ccr2 Receptor Antagonists
10/25/2007US20070249670 Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
10/25/2007US20070249591 Biaryl Amino Acids and Their Use in Dna Binding Oligomers
10/25/2007US20070246134 Phenylnaphthylimidazole Compound and Usage of the Same
10/25/2007DE102006018778A1 Aufhell- und/oder Färbemittel mit N,N'- Oxalydiazolen und/oder Oximidyldiazolen Reducing and / or coloring with N, N'-Oxalydiazolen and / or Oximidyldiazolen
10/25/2007DE102006018345A1 Aufhell- und/oder Färbemittel mit Amidinen Reducing and / or coloring with amidines
10/25/2007DE102006017901A1 Aufhell- und/oder Färbemittel mit verbesserter Hautverträglichkeit Reducing and / or dyes with improved skin compatibility
10/25/2007CA2648202A1 Compositions useful as inhibitors of voltage-gated sodium channels
10/25/2007CA2647266A1 Process for making cytokine inhibiting compounds containing 4- and 5- imidazolyl rings and the intermediates thereof
10/24/2007EP1847268A1 Multiple unit oral sustained release preparation and process for production of the same
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007EP1051401B1 Process for the production of formylimidazoles
10/24/2007CN101061103A Anthranilamide insecticides
10/24/2007CN101061099A High stability diionic liquid salts
10/24/2007CN101061090A Process for producing alpha, alpha-difluoroamine
10/24/2007CN101058560A Acidic ionic liquid based on 1-methyl-3-benzyl imidazole cation, synthetic method and use
10/24/2007CN101058559A Method of continuously synthesizing ionic liquid at room temperature
10/24/2007CN100344626C Alpha-substituted 2-methyl-5-nitroimidazole-1-ethanol derivatives
10/23/2007US7285681 Biguanide derivatives
10/23/2007US7285676 Synthesis of chiral 2-alkyl amino acids
10/23/2007US7285670 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-thiazole-4(S)-carboxylic acid by coupling a mono- or polyalkoxybenzonitrile with a cysteine ester and alkylating the thiazoline ring at the 4-carbon position; preferably a phase transfer agent such as N-9-anthracenylmethylcinchonidinium chloride is used
10/23/2007CA2172575C Aspartate-functional polyhydantoin prepolymers and their use in coating compositions
10/18/2007WO2007117692A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/18/2007WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007WO2007116092A1 Enzyme inhibitors
10/18/2007WO2007115935A1 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ACTIVE COMPOUNDS
10/18/2007US20070244268 Hardener for Epoxy Resin and Epoxy Resin Composition
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244175 Phytonutrient compositions from mushrooms or filamentous fungi and methods of use
10/18/2007US20070244156 Sulfonylamino-acetic acid derivatives
10/18/2007US20070244138 antiinflammatory agents
10/18/2007US20070244122 Derivatives of sulindac, use thereof and preparation thereof
10/18/2007US20070244117 Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof
10/18/2007US20070244108 Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors
10/18/2007CA2649209A1 Enzyme inhibitors
10/18/2007CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites
10/18/2007CA2648923A1 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases
10/18/2007CA2648074A1 11.beta.-hydroxysteroid dehydrogenase type 1 active compounds
10/17/2007EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor
10/17/2007EP1844028A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
10/17/2007EP1844020A1 Heterocyclic carboxamide compounds as steroid nuclear receptor ligands
10/17/2007EP1844019A2 Methode for the production of losartan
10/17/2007EP1844018A2 Crystalline forms fenoldopam mesylate
10/17/2007EP1843763A2 Compounds and compositions as ppar modulators
10/17/2007EP1742909A4 Anionic-sweetener-based ionic liquids and methods of use thereof
10/17/2007EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds
10/17/2007CN101056862A Novel imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
10/17/2007CN101054366A Method of synthesizing 1-methyl hydantoin
10/17/2007CN101054365A Method of synthesizing p-N-imidazolyl benzaldehyde
10/17/2007CN101054362A Method of synthesizing ion liquid at room temperature
10/17/2007CN100343285C Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method
10/17/2007CN100343249C 2,4,4-trisubstituted-1,3-dioxolane antifungals
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282512 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis
10/16/2007US7282501 Drugs for treatment of Syndrome X, diabetes, hypoglycemic agents, antilipemic agents, arteriosclerosis and cardiovascular agents
10/16/2007CA2261829C Intermediates for the preparation of 2-imidazoline-5-ones
1 ... 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 ... 345